Imagine making food out of thin air. Not as a metaphor, literally pulling protein from carbon dioxide, hydrogen, and a colony of hungry microbes, no farm or animal required. Finland's Solar Foods has been chasing that idea for nearly a decade, and on June 18 it landed a €77.8 million ($89.2 million) package of grants and loans from Business Finland to build its first commercial-scale factory.

It's a headline number for a company with a genuinely sci-fi product. The catch sits right there in the announcement, though, and Solar Foods didn't hide it. The money is contingent on the company raising additional financing first. The state has committed. Now the private market has to follow.

That conditional structure tells you a lot about where novel-protein funding stands right now. The technology has graduated from impossible to plausible. The question investors keep asking is whether it can ever be cheap enough to matter, and a government willing to put nearly 78 million euros on the table is a strong nudge toward yes.

Solar Foods makes a protein it calls Solein, and the process behind it is the part that makes people lean forward. Most of the world's protein comes from plants or animals that, in turn, eat sugars. Solar Foods skips all of that. Its microbes feed on gases.

Feed those microbes carbon dioxide, hydrogen, and a few minerals, and they grow into a protein-rich powder through gas fermentation. No fields. No livestock. No dependence on weather or arable land. In theory you could make it next to a power plant in a desert or, eventually, on a spacecraft, which is exactly the kind of detail that gets a deep-tech founder invited onto stages.

The company is a 2017 spin-off from VTT Technical Research Centre of Finland and LUT University, and it sits among a small handful of players building protein from gases rather than sugars. That feedstock choice is the whole pitch. Sugar-based fermentation competes with agriculture for crops. Gas-based fermentation doesn't compete with anything you'd want to eat.

Solar Foods already runs a pilot plant, Factory 01, which is scaling toward 230 tonnes of Solein per year. That's enough to prove the process and seed early product launches. It is nowhere near enough to feed a market.

Factory 02 is the real swing. Phase one targets 3,200 tonnes per year, more than a tenfold jump, with a hoped-for opening in late 2028. Getting there means working with a network of strategic partners to handle the real estate, hydrogen production, electricity grids, and the cooling and heating capacity a plant like this devours.

Notice how much of that has nothing to do with microbes. Cheap green hydrogen. Reliable renewable power. Industrial real estate. The biology is solved. The bottleneck is the surrounding infrastructure and the capital to assemble it, which is precisely why the Business Finland package matters and why it comes with strings.

Here's an irony Solar Foods has to live with. A Finnish company making a European answer to industrial protein has an easier path to market almost everywhere except home. Solein has secured novel-foods approval in Singapore and self-affirmed GRAS status in the United States, while it's still awaiting a decision from EFSA on its novel-foods submission in the EU.

CEO Rami Jokela has the regulatory map most foodtech founders know by heart. Singapore moves fast and loves being first. The US has a workable self-GRAS route. Europe, with EFSA, is thorough, cautious, and slow. For a company headquartered in Finland, building a flagship factory in Finland, that European timeline is the one that stings.

None of it has stopped the company from pushing ahead. Jokela has spent his tenure positioning Solar Foods as a serious industrial player rather than a science project, and a nearly nine-figure state package is the kind of validation that helps that case considerably.

Business Finland doesn't hand out 78 million euros lightly, and the size of the commitment says something about how Finland sees this. Food security has climbed the policy agenda across Europe, and a domestic technology that can produce protein without imported feed, fertile land, or livestock is strategically attractive in a way that goes beyond climate.

There's an industrial logic too. Finland has cheap renewable power, deep engineering talent, and a research base that produced this company in the first place. Building a novel-protein industry at home plays to all three. If gas fermentation becomes a real category, Finland would rather host the factories than import the powder.

Climate sits underneath all of it. Conventional protein, especially from animals, carries an enormous land and emissions footprint. A process that makes protein from CO2 and renewable hydrogen flips that equation, at least on paper. Whether it does so at a price anyone will pay is the multi-billion-euro question every investor in this space is circling.

Here's the question that decides everything, and it has nothing to do with biology. Can Solein be made cheaply enough to compete with soy, pea protein, or whey? Because the climate story only matters if the product reaches a price normal buyers will actually pay.

Right now the honest answer is not yet. Novel proteins made through fermentation tend to cost far more than commodity alternatives, and the only way that gap closes is scale. Bigger factories spread fixed costs across more output, cheaper green hydrogen lowers the input bill, and falling renewable power prices do the rest. Factory 02 is essentially a bet that scale bends the cost curve far enough.

That's exactly why the financing structure is so revealing. A government grant de-risks the build, but private investors won't pile in until they believe the unit economics can work at commercial volume. The whole package, in other words, is a wager that the second factory proves what the pilot couldn't: that protein from air can be not just possible, but affordable.

Solar Foods belongs to a tiny global club building protein from gases rather than crops, and the race between them is quietly intense. A few US and European players are chasing variations of the same idea, each betting that gas fermentation can sidestep agriculture entirely. First-mover advantage in a category this new is real, because the first company to hit commercial scale sets the cost benchmark everyone else gets measured against.

Regulatory approvals are part of that race too. Every market Solein clears, from Singapore to the US, is a door a competitor still has to walk through. The EFSA decision pending in Europe is the big one for a Finnish company, and clearing it would hand Solar Foods a home-market head start that's hard to overstate.

None of this guarantees anything. Being early in a category that may never reach mass-market price parity is a lonely place to be. But if industrial protein from air becomes a real industry, the companies that built the first factories and won the first approvals will own the story. Solar Foods is sprinting to be one of them.

Solar Foods is at the make-or-break stage every deep-tech company eventually reaches, where a clever process has to become a financeable factory. The state has done its part. The conditional structure of the package now puts the spotlight on private investors and strategic partners to close the rest.

If they do, and Factory 02 opens on schedule in 2028, Finland gets a genuine first-mover position in a protein category that didn't exist a decade ago. If the financing stalls, Solein stays a brilliant pilot with a small footprint and a long list of approvals it can't fully use.

Either way, the experiment is worth watching. Making food from air sounds like science fiction right up until someone builds the factory. Solar Foods just got the clearest signal yet that its government wants that factory built at home.